公开(公告)号：US20070197558A1

公开(公告)日：2007-08-23

申请号：US11613825

申请日：2006-12-20

申请人： David Betebenner ,  David DeGoey ,  Clarence Maring ,  Allan Krueger ,  Nobuhiko Iwasaki ,  Todd Rockway ,  Curt Cooper ,  David Anderson ,  Pamela Donner ,  Brian Green ,  Dale Kempf ,  Dachun Liu ,  Keith McDaniel ,  Darold Madigan ,  Christopher Motter ,  John Pratt ,  Jason Shanley ,  Michael Tufano ,  Rolf Wagner ,  Rong Zhang ,  Akhteruzzaman Molla ,  Hongmei Mo ,  Tami Pilot-Matias ,  Sherie Masse ,  Robert Carrick ,  Wenping He ,  Liangjun Lu ,  David Grampovnik

发明人： David Betebenner ,  David DeGoey ,  Clarence Maring ,  Allan Krueger ,  Nobuhiko Iwasaki ,  Todd Rockway ,  Curt Cooper ,  David Anderson ,  Pamela Donner ,  Brian Green ,  Dale Kempf ,  Dachun Liu ,  Keith McDaniel ,  Darold Madigan ,  Christopher Motter ,  John Pratt ,  Jason Shanley ,  Michael Tufano ,  Rolf Wagner ,  Rong Zhang ,  Akhteruzzaman Molla ,  Hongmei Mo ,  Tami Pilot-Matias ,  Sherie Masse ,  Robert Carrick ,  Wenping He ,  Liangjun Lu ,  David Grampovnik

IPC分类号： A61K31/519 ,  C07D498/02 ,  C07D487/02

CPC分类号： C07D487/04 ,  C07D471/04 ,  C07D475/06 ,  C07D495/04 ,  C07D513/04

摘要： Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

摘要翻译： 公开了有效抑制丙型肝炎病毒（“HCV”）或其他病毒复制的化合物。 本发明还涉及包含这些化合物的组合物，这些化合物与其它抗病毒剂或治疗剂的共同配制或共同给药，用于合成这些化合物的方法和中间体，以及使用这些化合物治疗 HCV或其他病毒感染。

公开(公告)号：US20070232645A1

公开(公告)日：2007-10-04

申请号：US11613836

申请日：2006-12-20

申请人： Todd Rockway ,  David Betebenner ,  Allan Krueger ,  Nobuhiko Iwasaki ,  Curt Cooper ,  David Anderson ,  Dale Kempf ,  Darold Madigan ,  Christopher Motter ,  Jason Shanley ,  Michael Tufano ,  Rolf Wagner ,  Rong Zhang ,  Akhteruzzaman Molla ,  Hongmei Mo ,  Tami Pilot-Matias ,  Sherie Masse ,  Robert Carrick ,  Wenping He ,  Liangjun Lu

发明人： Todd Rockway ,  David Betebenner ,  Allan Krueger ,  Nobuhiko Iwasaki ,  Curt Cooper ,  David Anderson ,  Dale Kempf ,  Darold Madigan ,  Christopher Motter ,  Jason Shanley ,  Michael Tufano ,  Rolf Wagner ,  Rong Zhang ,  Akhteruzzaman Molla ,  Hongmei Mo ,  Tami Pilot-Matias ,  Sherie Masse ,  Robert Carrick ,  Wenping He ,  Liangjun Lu

IPC分类号： A61K31/4375 ,  C07D471/02 ,  C12N7/06

CPC分类号： C07D471/04

摘要： Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

公开(公告)号：US20070232627A1

公开(公告)日：2007-10-04

申请号：US11613810

申请日：2006-12-20

申请人： David Betebenner ,  David DeGoey ,  Clarence Maring ,  Allan Krueger ,  Nobuhiko Iwasaki ,  Todd Rockway ,  Curt Cooper ,  David Anderson ,  Pamela Donner ,  Brian Green ,  Dale Kempf ,  Dachun Liu ,  Keith McDaniel ,  Darold Madigan ,  Christopher Motter ,  John Pratt ,  Jason Shanley ,  Michael Tufano ,  Rolf Wagner ,  Rong Zhang ,  Akhteruzzaman Molla ,  Hongmei Mo ,  Tami Pilot-Matias ,  Sherie Masse ,  Robert Carrick ,  Wenping He ,  Liangjun Lu ,  David Grampovnik

发明人： David Betebenner ,  David DeGoey ,  Clarence Maring ,  Allan Krueger ,  Nobuhiko Iwasaki ,  Todd Rockway ,  Curt Cooper ,  David Anderson ,  Pamela Donner ,  Brian Green ,  Dale Kempf ,  Dachun Liu ,  Keith McDaniel ,  Darold Madigan ,  Christopher Motter ,  John Pratt ,  Jason Shanley ,  Michael Tufano ,  Rolf Wagner ,  Rong Zhang ,  Akhteruzzaman Molla ,  Hongmei Mo ,  Tami Pilot-Matias ,  Sherie Masse ,  Robert Carrick ,  Wenping He ,  Liangjun Lu ,  David Grampovnik

IPC分类号： A61K31/519 ,  A61K31/4375 ,  C07D239/70 ,  C07D471/02 ,  C12N7/06

CPC分类号： C07D471/04 ,  C07D495/04 ,  C07D513/04

摘要： Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.